Breakthrough in Cancer Detection: SALSA Tool Exhibits Near-Perfect Accuracy in Liver Tumor Segmentation
Vall d'Hebron Institute of Oncology's Radiomics Group has developed SALSA, a deep learning-driven tool for the precise and automated detection and monitoring of liver tumors, also known as hepatocellular carcinoma. This innovative tool uses medical images, including computed tomography (CT) scans, to detect and delineate liver tumors, both primary and metastatic, at an accuracy rate of over 99%. SALSA aims to enhance cancer detection, treatment planning, and response evaluation, addressing the clinical challenges associated with liver cancer diagnosis and treatment.
Key Takeaways:
- SALSA is a fully automated tool that uses deep learning to detect and delineate liver tumors from medical images, including CT scans.
- The tool has shown superior accuracy for cancer detection and precise quantification of tumor burden, surpassing state-of-the-art models and radiologists' agreement.
- SALSA demonstrated high accuracy tumor detection with precision of over 99% at the patient level and a lesion-by-lesion detection precision of almost 82% in the external validation cohort.
- The tool has the potential to enhance cancer detection, treatment planning, and response evaluation, and could be useful in the management of patients with liver cancer.
- SALSA was trained on a dataset of 1598 computed tomography scans of 4908 primary or metastatic liver tumors.
- The tool requires no prior manual prompt requirements and can provide a more precise quantification of tumor burden, a crucial factor in cancer prognosis and treatment.
Statistics:
- SALSA achieved an accuracy rate of over 99% in detecting liver tumors at the patient level.
- The tool demonstrated a lesion-by-lesion detection precision of almost 82% in the external validation cohort.
- The SALSA tool was trained on a dataset of 1598 computed tomography scans from 4908 patients.
- The tool has shown potential to enhance cancer detection, treatment planning, and response evaluation in liver cancer patients.
Sources:
- VerticalNews Health, "Vall d'Hebron Institute of Oncology's Radiomics Group Develops SALSA Tool for Liver Tumor Segmentation" [1]
- Cell Reports Medicine, "SALSA: A System for Automatic Liver tumor Segmentation And detection" [2]
- CRIS Cancer Foundation, FERO Foundation, and "la Caixa" Foundation, which provided funding for various research projects led by VHIO's Radiomics Group.